In univariate cox analysis with clinicopathological characteristics, the PRDX1 was significantly related to the overall survival of HCC patients (TCGA-LIHC: Hazard ratio = 2.449, 95%Confidence interval = 1.452–4.129, p < 0.001; HCCDB18: Hazard ratio = 2.988, 95%Confidence interval = 1.462–6.098, p = 0.003) (Figures 10E, G). This evidence concerns the gene PRDX1 and hepatocellular carcinoma.